Signs and Symptoms of Clostridioides difficile Infection
The diagnosis of Clostridioides difficile infection (CDI) requires both clinical symptoms and a positive laboratory test, with diarrhea (defined as three or more unformed stools in 24 hours) being the primary symptom. 1, 2
Primary Clinical Manifestations
- Diarrhea: Three or more unformed stools within 24 hours is the hallmark symptom 1, 2
- Abdominal pain and cramps: Common accompanying symptoms that may range from mild to severe 1, 2
- Abdominal distension: Bloating and swelling of the abdomen 1
- Fever: Temperature >38.5°C may indicate severe infection 1
Laboratory and Clinical Markers of Severity
- Leukocytosis: WBC >15 × 10^9/L suggests severe infection 1
- Elevated serum creatinine: ≥133 μM/L or ≥1.5 times premorbid level indicates severe disease 1
- Hypoalbuminemia: Albumin <2.5 g/dL is associated with severe disease 1
- Elevated serum lactate: May indicate fulminant disease with organ failure 1
Severe and Complicated Presentations
- Pseudomembranous colitis: Visible on endoscopy as yellowish plaques on the colonic mucosa 1, 3
- Toxic megacolon: Severe, potentially life-threatening complication with colonic dilation 1
- Ileus: Signs of severely disturbed bowel function with decreased or absent bowel sounds 1
- Fulminant colitis: Characterized by severe systemic inflammatory response, shock, and organ failure 1
- Colonic perforation: Rare but life-threatening complication with high mortality 1
Risk Factors That Should Raise Suspicion
- Recent antibiotic use: Particularly clindamycin, penicillins, cephalosporins, and fluoroquinolones 2, 4
- Recent hospitalization or healthcare facility exposure: Increases risk of exposure to C. difficile spores 2
- Advanced age: Elderly patients are at higher risk for both acquisition and severe outcomes 2
- Immunocompromised status: Including patients on glucocorticoids or chemotherapy 1
- Proton pump inhibitor use: Associated with increased risk of CDI 1
Diagnostic Approach
- Testing should only be performed on patients with clinically significant diarrhea (≥3 unformed stools in 24 hours) who are not taking laxatives 1, 4
- Two-step algorithm is recommended: starting with screening using GDH or NAAT (high sensitivity), followed by confirmation with toxin detection (higher specificity) 1, 2
- Perirectal swabs may be used for patients with severe CDI complicated by ileus who cannot produce stool specimens 1
Common Pitfalls and Caveats
- Asymptomatic colonization: 10-52% of certain populations may carry C. difficile without symptoms; testing and treatment are not recommended in these cases 1
- Post-infectious irritable bowel syndrome: Up to 35% of patients may have transient functional bowel disorder in the first two weeks after CDI resolution, but only 4.3% have persistent symptoms beyond three months 1
- "Test of cure" is not recommended: 56% of patients may asymptomatically shed C. difficile spores for up to six weeks after successful treatment 1
- Recurrent symptoms: May be due to either recurrent infection or post-infectious irritable bowel syndrome; distinguishing between these is important but challenging 1
Early recognition of symptoms and prompt diagnosis are crucial for effective management of CDI and can potentially improve outcomes while controlling transmission 1, 2.